Ultra-sensitive dual ELONA/SERS-RPA multiplex diagnosis of antimicrobial resistance

Tools

Hassanain, Waleed A. and Johnson, Christopher L. and Faulds, Karen and Keegan, Neil and Graham, Duncan (2024) Ultra-sensitive dual ELONA/SERS-RPA multiplex diagnosis of antimicrobial resistance. Analytical Chemistry, 96 (29). pp. 12093-12101. ISSN 0003-2700 (https://doi.org/10.1021/acs.analchem.4c02165)

[thumbnail of Hassanain-etal-AC-2024-Ultra-sensitive-dual-ELONA-SERS-RPA-multiplex-diagnosis]
Preview
 Text. Filename: Hassanain-etal-AC-2024-Ultra-sensitive-dual-ELONA-SERS-RPA-multiplex-diagnosis.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (3MB)| Preview

Abstract

Antimicrobial resistance (AMR) is a significant global health threat concern, necessitating healthcare practitioners to accurately prescribe the most effective antimicrobial agents with correct doses to combat resistant infections. This is necessary to improve the therapeutic outcomes for patients and prevent further increase in AMR. Consequently, there is an urgent need to implement rapid and sensitive clinical diagnostic methods to identify resistant pathogenic strains and monitor the efficacy of antimicrobials. In this study, we report a novel proof-of-concept magnetic scaffold-recombinase polymerase amplification (RPA) technique, coupled with an enzyme-linked oligonucleotide assay (ELONA) and surface-enhanced Raman scattering (SERS) detection, aimed at selectively amplifying and detecting the DNA signature of three resistant carbapenemase genes, VIM, KPC, and IMP. To achieve this, streptavidin-coated magnetic beads were functionalized with biotin-modified forward primers. RPA was conducted on the surface of the beads, resulting in an immobilized duplex amplicon featuring a single overhang tail specific to each gene. These tails were subsequently hybridized with recognition HRP probes conjugated to a complementary single-stranded oligonucleotide and detected colorimetrically. Additionally, they underwent hybridization with similar selective SERS probes and were measured using a handheld Raman spectrometer. The resulting quantification limits were at subpicomolar level for both assays, allowing the potential for early diagnosis. Moreover, we demonstrated the platform capability to conduct a multiplex RPA–SERS detection of the three genes in a single tube. Compared to similar approaches like PCR, RPA offers advantages of speed, affordability, and isothermal operation at 37 °C, eliminating the need for a thermal cycler. The whole assay was completed within <2 h. Therefore, this novel magnetic scaffold ELONA/SERS–RPA platform, for DNA detection, demonstrated excellent capability for the rapid monitoring of AMR in point-of-care applications, in terms of sensitivity, portability, and speed of analysis.

ORCID iDs

Hassanain, Waleed A. ORCID logoORCID: https://orcid.org/0000-0002-1533-4818, Johnson, Christopher L., Faulds, Karen ORCID logoORCID: https://orcid.org/0000-0002-5567-7399, Keegan, Neil and Graham, Duncan ORCID logoORCID: https://orcid.org/0000-0002-6079-2105;
CORE (COnnecting REpositories)